Goldman Sachs Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral
Tweet Send to a Friend
Goldman Sachs analyst Corinne Jenkins downgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
